{"id":329665,"date":"2025-08-09T04:36:19","date_gmt":"2025-08-09T04:36:19","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/329665\/"},"modified":"2025-08-09T04:36:19","modified_gmt":"2025-08-09T04:36:19","slug":"pregabalin-trance-drug-sold-freely-in-capital-fuels-rising-addiction-among-youth-latest-news-india","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/329665\/","title":{"rendered":"Pregabalin: \u2018Trance\u2019 drug sold freely in Capital fuels rising addiction among youth | Latest News India"},"content":{"rendered":"\n<p><b>New Delhi: <\/b>In the back alleys of Delhi or inside a government-run Jan Aushadhi Kendras, a quiet drug crisis is unfolding. The substance in question isn\u2019t heroin or cocaine \u2014 it\u2019s Pregabalin, a prescription medication meant to treat anxiety, epilepsy, and nerve pain.<\/p>\n<p>     <img decoding=\"async\" src=\"https:\/\/www.europesays.com\/uk\/wp-content\/uploads\/2025\/08\/Pregabalin--marketed-under-brand-names-such-as-Lyr_1754642308098.jpg\" alt=\"Pregabalin, marketed under brand names such as Lyrica, Alzain, and Axalid, is meant to be dispensed only with a doctor\u2019s prescription. (Representative photo)\" title=\"Pregabalin, marketed under brand names such as Lyrica, Alzain, and Axalid, is meant to be dispensed only with a doctor\u2019s prescription. (Representative photo)\"\/>   Pregabalin, marketed under brand names such as Lyrica, Alzain, and Axalid, is meant to be dispensed only with a doctor\u2019s prescription. (Representative photo)    <\/p>\n<p>But on Delhi\u2019s streets, it has earned a far more sinister reputation: the \u201ctrance drug.\u201d<\/p>\n<p>\u201cI used to take it just once a week for the high,\u201d said a 28-year-old who began using Pregabalin recreationally after friends introduced him to its effects. \u201cSoon I couldn\u2019t stop. Now I take it almost every day. And I\u2019ve never once been asked for a prescription.\u201d<\/p>\n<p>Pregabalin, marketed under brand names such as Lyrica, Alzain, and Axalid, is meant to be dispensed only with a doctor\u2019s prescription. But it is being sold freely \u2014 and illegally \u2014 across the Capital. An HT investigation revealed that the drug is readily available without a prescription at multiple Jan Aushadhi Kendras and private pharmacies, despite being a scheduled drug that should only be dispensed with a doctor\u2019s note.<\/p>\n<p>At five Jan Aushadhi outlets \u2014 in Munirka, CR Park, Alaknanda, Govindpuri, and Zakir Bagh \u2014 HT was able to buy multiple dosages of the drug (75mg, 150mg, and 300mg) without so much as a question. Ten-tablet strips cost as little as \u20b930 at these subsidised pharmacies, part of the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), which is meant to offer affordable generic medicines to the public.<\/p>\n<p><b>Also Read: <\/b><a href=\"https:\/\/www.hindustantimes.com\/cities\/chandigarh-news\/punjab-bans-sale-of-pregabalin-beyond-75mg-101725392596857.html\" data-vars-anchor-text=\"Punjab bans sale of pregabalin beyond 75mg\" target=\"_blank\" rel=\"noopener\">Punjab bans sale of pregabalin beyond 75mg<\/a><\/p>\n<p>In effect, the government\u2019s own welfare infrastructure is now helping to fuel an emerging addiction crisis.<\/p>\n<p>Officials from Delhi\u2019s drug control department refused to comment officially. However, one senior official who spoke on the condition of anonymity acknowledged the issue but said the department had not received any formal complaints. \u201cWe are aware that Pregabalin misuse is a growing concern. Punjab, in particular, has faced serious abuse of this drug among young people,\u201d the official said. \u201cBut since Pregabalin is not yet listed under Schedule H1, it becomes much harder to regulate its sale.\u201d<\/p>\n<p>The official confirmed that last year, the Punjab government formally wrote to the Centre requesting that Pregabalin be included in the H1 list of scheduled drugs &#8212; a classification that would require pharmacists to maintain sale records and dispense it only with a doctor\u2019s prescription. The Centre is yet to act on that.<\/p>\n<p><b>Seeking a high<\/b><\/p>\n<p>At first glance, Pregabalin might not seem like an obvious choice for abuse. It was developed to treat nerve-related conditions and anxiety. But users say it also offers a relaxed, floaty \u201cbuzz\u201d that has drawn comparisons to alcohol and Valium &#8212; without the hangover.<\/p>\n<p>\u201cI was told it\u2019s like alcohol but cheaper, and you don\u2019t get a hangover,\u201d said a 23-year-old software engineer who began using Pregabalin in 2022. \u201cI started with three pills. Eventually, I was taking more than a dozen a day.\u201d<\/p>\n<p>Now clean and out of rehab, he blames the easy access for fuelling his addiction. \u201cEven when I realised I was addicted, the pills were still easy to buy. No one stopped me. If pharmacies had asked for a prescription, maybe I wouldn\u2019t have spiralled so far.\u201d<\/p>\n<p>Many users said the addiction creeps up quietly.<\/p>\n<p>Another user, 25, said the drug\u2019s appeal lies in how subtle and slow the addiction can be. \u201cIt gave me a sense of confidence, a feeling that I could do anything. That\u2019s what made it so dangerous. You don\u2019t notice it taking over your life until it already has.\u201d<\/p>\n<p><b>No hurdles at pharmacies<\/b><\/p>\n<p>Experts say the lack of regulatory oversight is at the heart of the problem. While Pregabalin is a scheduled drug under Schedule H \u2014 which technically requires a prescription \u2014 it is not on the stricter H1 list, which mandates record-keeping and tighter controls.<\/p>\n<p>In Punjab, where the drug is locally nicknamed \u201cghoda (horse)\u201d due to its veterinary use and tranquilising effects, has already been placed under tighter restrictions. Sale of 150mg and 300mg doses is no longer permitted without special authorisation in several districts.<\/p>\n<p>But in Delhi, no such restrictions exist. HT was able to purchase multiple strips from both private and government pharmacies without any form of prescription or ID verification.<\/p>\n<p><b>Also Read: <\/b><a href=\"https:\/\/www.hindustantimes.com\/cities\/delhi-news\/19-charge-sheeted-for-last-year-s-1-200kg-drug-bust-in-delhi-101749838062399.html\" data-vars-anchor-text=\"19 charge-sheeted for last year\u2019s 1,200kg drug bust in Delhi\" target=\"_blank\" rel=\"noopener\">19 charge-sheeted for last year\u2019s 1,200kg drug bust in Delhi<\/a><\/p>\n<p>When contacted, the Delhi Chemists Association denied that pharmacies were selling Pregabalin illegally. However, interviews with pharmacists suggest otherwise. \u201cIt\u2019s an open secret,\u201d said one pharmacist in South Delhi, who admitted to selling the drug off the record. \u201cWe don\u2019t give it to everyone \u2014 only to regular customers. As long as they don\u2019t create trouble, it\u2019s fine. We\u2019ve been doing this for years.\u201d<\/p>\n<p><b>Left on dependency<\/b><\/p>\n<p>Doctors at de-addiction centres across Delhi say they are now seeing a growing number of young adults \u2013 often between 16 and 35 \u2013 checking in for Pregabalin abuse.<\/p>\n<p>\u201cSome of the worst cases are taking up to 1,800 mg a day \u2013 that\u2019s around 20 pills,\u201d said Dr Shabiullah Sayyed, a psychologist at Rainbow Hospital.<\/p>\n<p>\u201cAnd the problem is they didn\u2019t even think they were doing something dangerous at first. It\u2019s not heroin. It\u2019s not smack. It\u2019s just a pill from a chemist.\u201d<\/p>\n<p>Another psychologist from the God\u2019s Will Rehab Centre noted that the trend is similar to earlier waves of Tramadol or codeine syrup abuse. \u201cThere is an urgent need to address over-the-counter drug abuse, especially among youngsters. There should be stricter regulations and public awareness.\u201d<\/p>\n<p>Pregabalin is not currently listed under the Narcotic Drugs and Psychotropic Substances (NDPS) Act \u2014 which means there\u2019s no legal penalty for possessing or distributing it.<\/p>\n<p><b>Need for regulation<\/b><\/p>\n<p>In September 2023, several district magistrates in Punjab imposed local restrictions on the sale of Pregabalin above 75mg and urged the Centre to bring the drug under Schedule H1. But no national-level action has followed.<\/p>\n<p>Experts say the Centre must act immediately.\u201cWhile the hospital has not yet received any additional case of Pregabalin but definitely, many patients who were prescribed the drug have shown the signs of dependency of the drug,\u201d said Dr Rajinder K Dhamija, director of the Institute of Human Behaviour &amp; Allied Sciences (IHBAS).<\/p>\n<p>He added that unless the drug is reclassified under H1 and subject to NDPS-like control, the number of new addicts will continue to grow.<\/p>\n<p><b>Also Read: <\/b><a href=\"https:\/\/www.hindustantimes.com\/cities\/delhi-news\/manas-proves-effective-delhi-registers-16-drug-related-cases-this-year-101754589375758.html\" data-vars-anchor-text=\"\u2018MANAS\u2019 proves effective: Delhi registers 16 drug-related cases this year\" target=\"_blank\" rel=\"noopener\">\u2018MANAS\u2019 proves effective: Delhi registers 16 drug-related cases this year<\/a><\/p>\n<p>But for those who have struggled with addiction, the drug\u2019s easy availability remains a source of deep frustration \u2013 and sadness.<\/p>\n<p>\u201cI sometimes think my life could have been very different if the pharmacist had just said no,\u201d said the software engineer, now clean after months in rehab.<\/p>\n<p>\u201cFirst few times being on it feels euphoric; soon it becomes a hell\u2026 Maybe if I needed a prescription, I wouldn\u2019t have started. Or I\u2019d have stopped sooner.\u201d<\/p>\n<p>He pauses.<\/p>\n<p>\u201cBut no one ever asked.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"New Delhi: In the back alleys of Delhi or inside a government-run Jan Aushadhi Kendras, a quiet drug&hellip;\n","protected":false},"author":2,"featured_media":329666,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4315],"tags":[9776,13180,535,105,4326,60638,34270,16,15,50],"class_list":{"0":"post-329665","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-addiction","9":"tag-capital","10":"tag-drugs","11":"tag-health","12":"tag-medication","13":"tag-rising","14":"tag-sold","15":"tag-uk","16":"tag-united-kingdom","17":"tag-youth"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/114996955270655975","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/329665","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=329665"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/329665\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/329666"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=329665"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=329665"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=329665"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}